Combination products: modernizing the regulatory paradigm
- PMID: 28496147
- DOI: 10.1038/nrd.2017.66
Combination products: modernizing the regulatory paradigm
Abstract
New opportunities to develop innovative - and often complex - products that combine drugs, devices and/or biological components are rapidly emerging, raising questions about how such products should be regulated. Here, we discuss the ongoing efforts of the FDA to develop a modern, transparent, flexible and consistent science-based regulatory approach for combination products.
References
-
- Science. 2015 Nov 27;350(6264):1084-9 - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
